VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹648 Cr | ₹601 Cr | ₹556 Cr | ₹600 Cr | ₹548 Cr |
What is the latest Revenue of VENUS REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹648 Cr |
| Mar2024 | ₹601 Cr |
| Mar2023 | ₹556 Cr |
| Mar2022 | ₹600 Cr |
| Mar2021 | ₹548 Cr |
How is Revenue of VENUS REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹648 Cr | 7.72 | |
| Mar2024 | ₹601 Cr | 8.27 | |
| Mar2023 | ₹556 Cr | -7.44 | |
| Mar2022 | ₹600 Cr | 9.50 | |
| Mar2021 | ₹548 Cr | - | |
Compare Revenue of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,366.4 Cr | -2% | 11.7% | 239.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,209.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,750.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,746.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,851.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,268.4 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -2% |
11.7% |
239.1% |
| SENSEX | 1.3% |
5.3% |
6.3% |
You may also like the below Video Courses